IgA nephropathy (IgAN), which is also known as Berger’s disease, is a chronic kidney disorder. It is characterized by the accumulation of immunoglobulin A (IgA) deposits in the glomeruli. This progressive condition can lead to problems such as inflammation, impaired kidney function, and ultimately end-stage renal disease if left unmanaged.

Advancing research in this area depends heavily on access to high-quality Nephropathy Research Samples, including both tissue and biofluid specimens. These biospecimens help scientists investigate disease mechanisms, identify biomarkers, and develop targeted therapies for IgA nephropathy kidney disease.

At Bay Biosciences, we provide well-characterized Nephropathy Research Samples & biospecimens that support translational and clinical research, helping accelerate scientific discovery in nephrology.

Tissue and Biofluid Samples in IgA Nephropathy (IgAN) Research

Understanding IgA Nephropathy Kidney Disease

IgA nephropathy develops when the immune system produces structurally abnormal IgA1 molecules. These molecules exhibit defective glycosylation, which increases their tendency to form immune complexes.

These immune complexes circulate in the bloodstream and deposit in the kidney’s glomerular mesangium. Once deposited, they trigger an inflammatory response involving mesangial cell proliferation, complement system activation, cytokine release, and progressive glomerular injury.

Over time, this damages the kidney’s filtration system and results in an overall decline in renal function.

Researchers heavily rely on Nephropathy Research Samples to study these pathological processes at both the molecular and cellular levels.

IgA Nephropathy Symptoms and Causes

Understanding IgA nephropathy symptoms and causes is essential for early detection, treatment and research development.

Common Symptoms

Causes and Risk Factors

The exact cause of IgA nephropathy remains unclear, but research suggests a mix of contributing factors, which include genetic predisposition and environmental triggers.

Firstly, certain genetic factors influence susceptibility to abnormal IgA production. Studies have shown that IgA nephropathy often clusters in families and is more common in certain populations.

In addition, genome-wide association studies  have also identified the role of HLA alleles including HLA-DRB1 and HLA-DQB1 as important in the development of disease.

Secondly, environmental triggers such as HIV and bacterial infections can also pose risk.

Thirdly, liver disease and celiac disease are also linked to IgA.

Diagnosis of IgA Nephropathy

IgA nephropathy is often detected first when a person notices blood in their urine or during a routine urine test.

To confirm the condition, doctors perform several tests, including urine tests, blood tests, biopsy tests, and the iothalamate clearance test.

Firstly, urine tests help check how well the kidneys are working and look for blood or protein, which may indicate inflammation in the kidney filters (glomeruli).

Secondly, blood tests measure waste products like creatinine or cystatin C, and high levels suggest reduced kidney function.

Thirdly, a kidney biopsy is done, which is also the only way to fully confirm the disease. Kidney biopsy is also considered to be the gold standard for diagnosing IgA nephropathy and studying its pathology.

Finally, in some cases, doctors may also use an iothalamate clearance test to evaluate how effectively the kidneys filter waste.

Treatment of IgA Nephropathy

Treatment plans vary based on disease severity, however, some common methods include:

Blood Pressure Control

Managing blood pressure is one of the most important parts of treatment because high blood pressure weakens the kidneys. Doctors commonly prescribe ACE inhibitors or ARBs to lower blood pressure and reduce protein loss in urine.

Tight blood pressure control can significantly slow the progression of kidney damage.

Omega-3 Fatty Acids

Omega-3 fatty acids can reduce inflammation in the kidneys.

Cholesterol Management

High cholesterol is common in kidney disease and can worsen kidney damage. Therefore, doctors may prescribe cholesterol medication to lower cholesterol levels.

Diuretics

Diuretics are used to reduce swelling (edema) in the hands, feet, and face, and to help control blood pressure.

Lifestyle and Supportive Care

Doctors also recommend lifestyle changes to support treatment, such as:

  • Reducing salt intake to control blood pressure and swelling
  • Following a kidney-friendly diet
  • Maintaining a healthy weight
  • Avoiding smoking

Advanced Treatment Options

In case of a kidney failure, doctors may recommend dialysis or a kidney transplant.

IgA Nephropathy Samples for Research

High-quality IgA Nephropathy Samples for Research are essential for studying disease pathology and developing effective therapies. These samples include both kidney tissue and various biofluids that reflect systemic and localized disease processes.

Tissue Samples in Nephropathy Research

1. Formalin-Fixed Paraffin-Embedded (FFPE) Tissue

Researchers use FFPE samples for immunohistochemistry, protein expression analysis, and retrospective clinical studies. Researchers can also use FFPE-derived microarrays for transcriptome profiling. Studies have shown that FFPE samples work reliably for analyzing gene expression patterns.

2. Fresh Frozen Tissue

Fresh frozen kidney tissue preserves RNA, DNA, and proteins in their native state. Researchers can use these samples for transcriptomics, proteomics, and genomic profiling. These advanced analyses help identify molecular pathways involved in disease progression.

Biofluid Samples in Nephropathy Research

1. Blood Samples (Serum and Plasma)

Blood-based Nephropathy Research Samples are widely used to study circulating biomarkers. These include galactose-deficient IgA1, autoantibodies, cytokines, complement proteins, and metabolic markers. These components help researchers understand immune dysregulation in IgA nephropathy kidney disease.

2. Urine Samples

Urine plays a critical role in kidney disease research because it directly reflects renal function. Researchers can evaluate proteinuria, hematuria, and kidney injury biomarkers such as NGAL and KIM-1. Urinary extracellular vesicles and exosomes also provide valuable molecular insights.

3. Peripheral Blood Mononuclear Cells (PBMCs)

PBMCs include lymphocytes and monocytes that regulate immune responses. Researchers use these cells to study immune activation, cytokine production, and gene expression changes associated with IgA nephropathy.

Supporting Your Research with Bay Biosciences

Tissue and biofluid specimens play a central role in advancing IgA nephropathy research. Nephropathy Research Samples provide critical insights into disease mechanisms, immune dysregulation, and biomarker discovery.

By integrating tissue pathology with systemic biofluid analysis, researchers can develop more accurate diagnostic tools and targeted therapies for IgA nephropathy kidney disease.

Bay Biosciences supports this progress by providing high-quality, well-characterized biospecimens.

Our comprehensive range of IgA Nephropathy Samples for Research includes:

Samples from normal healthy donors, volunteers, for controls, and clinical research are also

available.

If you have any questions, concerns, or special requests, please don’t hesitate to reach out to us!